Synthetic glycolipid-like constructs as tools for glycobiology research, diagnostics, and as potential therapeutics

Biochemistry (Moscow)

Volumn 80, Issue 7, 2015, Pages 857-871

  Korchagina, E Y ^a   Henry, S M ^b  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

function spacer lipid; KODE technology; kodecyte; neoglycolipid

Indexed keywords

ANIMALIA;

ANTIBODY; GLYCOLIPID; LIPID; POLYSACCHARIDE;

ANIMAL; CELL MEMBRANE; CHEMISTRY; GLYCOBIOLOGY; HUMAN; METABOLISM; PROCEDURES; SYNTHESIS;

ANIMALS; ANTIBODIES; CELL MEMBRANE; GLYCOLIPIDS; GLYCOMICS; HUMANS; LIPIDS; POLYSACCHARIDES;

EID: 84937712831     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297915070068     Document Type: Review

References (57)

1. Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., and Etzler, M. E. (2009) Essentials of Glycobiology, 2nd Edn., Cold Spring Harbor Laboratory Press, N.Y.
2. Tailor, M. E., and Drickamer, K. (2006) Introduction to Glycobiology, Oxford University Press, N.Y.
3. Marcus, D. M., and Cass, L. E. (1969) Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes, Science, 164, 553-555.
4. Sneath, J. S., and Sneath, P. H. A. (1955) Transformation of the Lewis groups of human red cells, Nature, 176, 172.
5. Simons, K., and Ikonen, E. (1997) Functional rafts in cell membranes, Nature, 387, 569-572.
6. Simons, K., and Ikonen, E. (2000) How cells handle cholesterol, Science, 290, 1721-1726.
7. Tang, P. W., Gool, H. C., Hardy, M., Lee, Y. C., and Feizi, T (1985) Novel approach to the study of the antigenicities and receptor functions of carbohydrate chains of glycoproteins, Biochem. Biophys. Res. Commun., 132, 474-480.
8. Palma, A. S., Feizi, T, Childs, R. A., Chai, W, and Liu, Y (2014) The neoglycolipid (NGL)-based oligosaccharide microarray system poised to decipher the meta-glycome, Curr. Opt. Chem. Biol., 18, 87-94.
9. Liu, Y., Feizi, T., Campanero-Rodes, M. Z., Childs, R. A., Zhang, Y, Mullou, Y. B., Evans, Ph. G., Osborn, H. M. I., Otto, D., Crocker, P. R., and Chai, W. (2007) Neoglycolipid probes prepared via oxime ligation for microarray analysis of oligosaccharide-protein interaction, Chem. Biol., 14, 847-859.
10. Hasegawa, A., and Kiso, M. (1994) Synthesis of sialyl Lewis X ganglioside and analogs, Methods Enzymol., 242, 158-173.
11. Ando, T, Imamura, A., Ishida, H., and Kiso, M. (2007) 1.20. Synthesis of glycolipids, Compr. Glycosci., 1, 797-813.
12. Faivre, V., de Lourdes Costa, M., Boullanger, P., Baszkin, A., and Rosilio, V. (2003) Specific interaction of lectins with liposomes and monolayers, Chem. Phys. Lipids, 125, 147-159.
13. Miyashita, H., Ikeda, T, and Nohara, T (2007) Synthesis of neosaponins and neoglycolipid containing a chacotriosyl moiety, Carbohydr. Res., 342, 2182-2191.
14. Queneau, Y, Chambert, S., Besseta, S., and Cheai, R. (2008) Recent progress in the synthesis of carbohydratebased amphiphilic materials: the examples of sucrose and isomaltulose, Carbohydr. Res., 343, 1999-2009.
15. Korchagina, E., Tuzikov, A., Formanovsky, A., Popova, I., Henry, S., and Bovin, N. (2012) Toward creating cell membrane glycolandscapes with glycan lipid constructs, Carbohydr. Res., 356, 238-246.
16. Barr, K., Korchagina, E., Popova, I., Bovin, N., and Henry, S. (2015) Monoclonal anti-A activity against the FORS1 (Forssman) antigen, Transfusion, 55, 129-136.
17. Blake, D. A., Bovin, N. V., Bess, D., and Henry, S. M. (2011) FSL constructs: a simple method for modifying cell/virion surfaces with a range of biological markers without affecting their viability, J. Vis. Exp., 54, e3289; DOI: 10.3791/3289.
18. Barr, K., Korchagina, E., Ryzhov, I., Bovin, N., and Henry, S. (2014) Mapping the fine specificity of ABO monoclonal reagents with A and B type-specific FSL constructs in kodecytes and inkjet printed on paper, Transfusion, 54, 2477-2484.
19. Carter, N. L., Blake, D. A., Bovin, N. V., Henry, S. M., Korchagina, E. Y, Williams, E. C., and Tuzikov, A. B. (2006) Cell Surface Coating with Hyaluronic Acid Oligomer Derivative, US Patent WO/2007/035116.
20. Harrison, A. L., Olsson, M. L., Brad Jones, R., Ramkumar, S., Sakac, D., Binnington, B., Henry, S., Lingwood, C. A., and Branch, D. R. (2010) A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms, Glycoconj. J., 27, 515-524.
21. Oliver, C., Blake, D., and Henry, S. (2011) In vivo neutralization of anti-A and successful transfusion of A antigen incompatible red cells in an animal model, Transfusion, 51, 2664-2675.
22. Lan, C.-C., Blake, D., Henry, S., and Love, D. R. (2012) Fluorescent function-spacer-lipid construct labelling allows for real-time in vivo imaging of cell migration and behavior in zebrafish (Danio rerio), J. Fluoresc., 22, 1055-1063.
23. Bovin, N. V., and Khorlin, A. Ya. (1984) Synthesis of the determinant oligosaccharides of ABH (type 1) blood group antigens and Leb tetrasaccharide from the same precursor, Bioorg. Khim., 10, 853-860.
24. Bovin, N. V., and Khorlin, A. Ya. (1985) Convenient method for preparing the Le and ABH (type 1) determinant oligosaccharides, Bioorg. Khim., 11, 826-829.
25. Bovin, N. V., Zemlyanukhina, T V., Chagiashvili, C. N., and Khorlin, A. Ya. (1988) Artificial antigens and affinity sorbents of blood-group specificity Lea, Leb, and Led, Khim. Prirod. Soedin., 6, 777-785.
26. Zemlyanukhina, T V., and Bovin, N. V. (1990) Synthesis of blood group oligosaccharides with A, B, and H (type 3) specificity, Bioorg. Khim., 16, 1096-1104.
27. Korchagina, E. Yu., and Bovin, N. V. (1992) Synthesis of spacered trisaccharides with blood group specificities A and B, their fragments and structural analogs, Bioorg. Khim., 18, 283-298.
28. Ovchinnikova, T V., Ter-Grigoryan, A. G., Pazynina, G. V., and Bovin, N. V. (1997) Synthesis of terminal disaccharide of Forssman antigen and some of its analogs as spacered glycosides and free disaccharides, Rus. J. Bioorg. Chem., 23, 55-68.
29. Simeoni, L. A., Byramova, N. E., and Bovin, N. V. (1997) Synthesis of aminopropyl glycoside of the SiaTn antigen Neu5Aca2-6GalNAca, Russ. J. Bioorg. Chem., 23, 683691.
30. Simeoni, L. A., Byramova, N. E., and Bovin, N. V. (2000) Neu5Gca(2-6)GalNAca as a spacer glycoside, Russ. J. Bioorg. Chem., 26, 183-191.
31. Pazynina, G. V., Tyrtysh, T V., and Bovin, N. V. (2002) Synthesis of histo blood-group antigens A and B (type 2), xenoantigen Gala1-3Galß1-4GlcNAc and related type 2 backbone oligosaccharides as haptens in spacered form, Mendeleev Commun., 12, 143-145.
32. Pazynina, G., Tuzikov, A., Chinarev, A., Obukhova, P., and Bovin, N. (2002) Simple stereoselective synthesis of a2-6 sialooligosaccharides, Tetrahedron Lett., 43, 8011-8013.
33. Korchagina, E. Y, Pochechueva, T. V., Obukhova, P. S., Formanovsky, A. A., Imberty, A., Rieben, R., and Bovin, N. V. (2005) Design of the blood group AB glycotopes, Glycoconj. J., 22, 127-133.
34. Byramova, N. E., Tuzikov, A. B., Tyrtysh, T V., and Bovin, N. V. (2007) 1,6-Anhydro-N-acetyl-ß-D-glucosamine in oligosaccharide synthesis: II. The synthesis of the spacered LeY tetrasaccharides, Rus. J. Bioorg. Chem., 33, 99-109.
35. Korchagina, E. Yu., Ryzhov, I. M., Byrgazov, K. A., Popova, I. S., Pokrovsky, S. N., and Bovin, N. V. (2009) Block synthesis of blood group tetrasaccharides B (types 1, 3 and 4), Mendeleev Commun., 19, 152-154.
36. Ryzhov, I. M., Korchagina, E. Y., Popova, I. S., and Bovin, N. V. (2012) Block synthesis of A tetrasaccharides (types 1, 3, and 4) related to the human ABO blood group system, Carbohydr. Res., 351, 17-25.
37. Pazynina, G., Tyrtysh, T, Nasonov, V., Belyanchikov, I., Paramonov, A., Malysheva, N., Zinin, A., Kononov, L., and Bovin, N. (2013) Divergent strategy for the synthesis of a2- 3-linked sialo-oligosaccharide libraries using a Neu5TFA- (a2-3)-Gal building block, Synlett, 24, 226-230.
38. Pazynina, G. V., Chinarev, A. A., Tuzikov, A. B., Nasonov, V. V., Malysheva, N. N., and Bovin, N. V. (2013) Synthesis of a spacer-armed 6'-sialyl-N-acetyllactosamine, in Carbohydrate Chemistry: Proven Synthetic Methods, Vol. 2, Series: Carbohydrate Chemistry, CRC Press, pp. 155-160.
39. Tuzikov, A. B., Gambaryan, A. S., Juneja, L. R., and Bovin, N. V. (2000) Conversion of complex sialooligosaccharides into polymeric conjugates and their anti-influenza virus inhibitory potency, J. Carbohydr. Chem., 19, 1191-1200.
40. Lee, R. T, and Lee, Y C. (1997) Facile synthesis of a highaffinity ligand for mammalian hepatic lectin containing three terminal N-acetylglucosamine residues, Bioconj. Chem., 8, 762-765.
41. Cremer, P. S., and Boxer, S. G. (1999) Formation and spreading of lipid bilayers on planar glass support, J. Phys. Chem. B, 103, 2554-2559.
42. Nollert, P., Kiefer, H., and Jahnig, F. (1995) Lipid vesicle adsorption versus formation of planar bilayers on solid surfaces, Biophys. J., 69, 1447-1455.
43. Richter, R., Mukhopadhyay, A., and Brisson, A. (2003) Pathways of lipid vesicle deposition on solid surfaces: a com- bined QCM-D and AFM study, Biophys. J., 85, 3035-3047.
44. Radler, J., Strey, H., and Sackmann, E. (1995) Phenomenology and kinetics of lipid bilayers spreading on hydrophilic surfaces, Langmuir, 11, 4539-4548.
45. Whiles, J. A., Deems, R., Vold, R. R., and Dennis, E. A. (2002) Bicelles in structure-function studies of membraneassociated proteins, Bioorg. Chem., 30, 431-442.
46. Henry, S. (2009) Modification of red blood cells for laboratory quality control use, Curr. Opin. Hematol., 16, 467-472.
47. Oliver, C., Blake, D., and Henry, S. (2011) Modeling transfusion reactions and predicting in vivo cell survival with kodecytes, Transfusion, 51, 1723-1730.
48. Hult, A. K., Frame, T, Chesla, S., Henry, S., and Olsson, M. L. (2012) Flow cytometry evaluation of red blood cells mimicking naturally-occurring ABO subgroups following modification with variable amounts of FSL-A and B constructs, Transfusion, 52, 247-251.
49. Hadac, E. M., Federspiel, M. J., Chernyy, E., Tuzikov, A., Korchagina, E., Bovin, N. V., Russell, S., and Henry, S. M. (2011) Fluorescein and radiolabeled function-spacer-lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions, J. Virol. Methods, 176, 78-84.
50. Perry, H., and Henry, S. (2015) Training students in serologic reaction grading increased perceptions of self-efficacy and ability to recognize serologic reactions but decreased grading accuracy, Transfusion, Jan. 7, DOI: 10.1111/ trf.12985 [Epub ahead of print].
51. Frame, T, Carroll, T, Korchagina, E., Bovin, N., and Henry, S. (2007) Synthetic glycolipid modification of red blood cell membranes, Transfusion, 47, 876-882.
52. Henry, S. M. (2005) Engineering the surface of red cells with synthetic glycolipids (KODE CAE) to create ABO analytical sensitivity controls and xeno-modified cells, Xenotransplantation, 12, 356.
53. Georgakopoulos, T, Komarraju, S., Henry, S., and Bertolini, J. (2012) An improved Fc function assay utilizing CMV antigen coated red blood cells generated with synthetic function-spacer-lipid constructs, Vox Sanguinis, 102, 72-78.
54. Perry, E. H., and Henry, S. M. (2013) Teaching the recognition of hemolysis by controlling antibody mediated in vitro hemolysis with kodecytes, Transfusion, 53 (Suppl.), 182A.
55. Henry, S. (2014) Magnetic Bead Coatings: Today and Tomorrow. Chap. 5. Rapid biofunctionalization of magnetic beads with function-spacer-lipid constructs, SepMag eBook (http://sepmag.eu/free-guide-magnetic-bead-coatings).
56. Svensson, L., Hult, A. K., Stamps, R., Angstrom, J., Teneberg, S., Jorgensen, R., Rydberg, L., Henry, S. M., and Olsson, M. L. (2013) Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system, Blood, 121, 1459-1468.
57. Henry, S., Korchagina, E., Tuzikov, A., and Bovin, N. V. (2010) Glyco-landscaping with neo glycolipid constructs, Glycobiology, 20, 1472.